YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

STL biotech startup raises $172M

Posted online

St. Louis biotechnology startup Wugen Inc. raised $172 million in a funding round.

The company plans to use the funds to advance clinical development of its cancer-fighting therapies, the St. Louis Business Journal reports.

The startup has raised more than $200 million to date.

Read more from the St. Louis Business Journal.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Fall 2026 Architects & Engineers Project Report

This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.

Most Read
Update cookies preferences